Opti­Nose files for $100M IPO; GSK wins three-in-one COPD OK

⇨ Yard­ley, PA-based Opti­Nose is join­ing the grow­ing line for Nas­daq, fil­ing for a $100 mil­lion IPO, ac­cord­ing to the S-1. The fil­ing came right on the heels of an OK for XHANCE — pre­vi­ous­ly re­ferred to by the de­vel­op­ment name OPN-375 — for the treat­ment of nasal polyps.

⇨ GSK got some good news to­day, win­ning FDA ap­proval of the first three-in-one once-dai­ly ther­a­py for COPD. The move comes af­ter the EMA en­dorsed the in­haler last week.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER